RSS Feed For (NASDAQ:AVNR)

AVANIR PHARMACEUT-A (NASDAQ:AVNR)

1.81 +0.01 (0.56%)
AVANIR PHARMACEUT-A (NASDAQ:AVNR) Delayed :
Previous Close $1.80    52 Week High $4.09 
Open $1.79    52 Week Low $0.23 
Day High $1.81    P/E N/A 
Day Low $1.77    EPS $-0.26 
Volume 320,917       
More AVNR Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker # Stories Ticker # Stories
RWC 2 SDTH 2
FTK 2 AHR 2
AMGN 2 BMY 2
JAV 2 BEXP 2
GSK 2 LLY 2
SATS 2 CIT 2
View All Friends, Peers and Foes

Entities who have mentioned AVNR

View All Entities

StreetInsider.com Major News for AVNR

Aug 11, 2009 07:34 AM AVANIR (AVNR) Higher After Zenvia Met Primary Endpoint
Dec 15, 2008 08:43 AM AVANIR (AVNR) Reports a Q4 Loss

View All ReportsStreetInsider.com Reports on AVNR

Nov 10, 2009 09:08 AM AVANIR Pharma (AVNR) Announces Results from Zenvia Phase III STAR Trial
Oct 13, 2009 01:58 PM AVANIR (AVNR) Higher As Phase III Trial Meets Efficacy Endpoint
Oct 9, 2009 10:27 AM Morning Movers 10/09: SCIL, MBRX, CAGC, AVNR, PSTA, SRZ, ELGX Higher; SPPI, ACOR, LXRX Lower
Oct 9, 2009 09:06 AM Avanair Pharma (AVNR) Announces Phase III Zenvia Results in MS Patients
Oct 7, 2009 09:16 AM AVANIR (AVNR) Receives Patent Coverage On Zenvia Well Into 2025
View All Reports

View All Press ReleasesCompany Press Releases on AVNR

Nov 17, 2009 08:30AM AVANIR Pharmaceuticals Invites Investors to Fourth Quarter and Fiscal Year End Conference Call
Nov 11, 2009 08:30AM AVANIR to Present at the Lazard Healthcare Conference
Nov 10, 2009 08:30AM Avanir Pharmaceuticals Announces Zenvia Safety and Efficacy Data from Star Trial Open Label Extension
Nov 3, 2009 06:50AM Trading Outlook for Avanir Pharmaceuticals Inc. Issued by InvestorSoup.com
Oct 20, 2009 08:30AM AVANIR to Present at the BIOCOM Investor Conference
View All Press Releases

StreetInsider Reports on AVNR by Category

View All BlogsBlogs on AVNR

Oct 9, 2009 04:18 PM Equities: Rally Revives as DJIA Hits Year's Highs
Oct 8, 2009 04:24 AM 15 Breakout Stocks on Huge Volume
Aug 11, 2009 04:26 PM Closing Update for Tuesday, August 11: Back-to-Back Losses
Aug 2, 2009 05:06 AM Extreme FDA Trades: 30 Stocks Under 5 Bucks
Jul 30, 2009 04:36 AM AVANIR Pharmaceuticals, Inc. F3Q09 (Qtr End 06/30/09) Earnings Call Transcript
View All Blogs

View All FilingsSEC Filings on AVNR

Nov 17, 2009 05:09PM Form 8-K AVANIR PHARMACEUTICALS, For: Nov 11
Oct 13, 2009 05:21PM Form 4 SCHREIBER ALAIN For: Oct 09
View All Filings

Comments on recent AVNR articles

mark
on Sep 11, 2009
at 10:55 AM ugh I bought this stock at $18.00..I wonder if I will ever see that again
Article: AVANIR Pharmaceuticals (AVNR) Files $75M Mixed Securities Shelf
Bob Marlett
on Sep 8, 2009
at 07:38 PM For what now? They just diluted the long term share holder by private placement of 4.5 mil. shares to raise money. What will the $75 do enrich the insiders even more while waiting for FDA approval of their only drug.
Article: AVANIR Pharmaceuticals (AVNR) Files $75M Mixed Securities Shelf
Bob Marlett
on Aug 27, 2009
at 08:51 AM Avanier stock sale Here we go again diluting the share value of the long term investor to support higher salaries, bonuses and stock options to enrich the insiders.
Article: AVANIR Pharma (AVNR) Raises Gross Proceeds of $10.6M Via Sale of 4.5M Shares

Comments on AVNR


No comments are currently available.